O-(D-glucopyranosylidene)amino-Z-N-2,6-Difluorophenylcarbamate

ID: ALA3785103

Chembl Id: CHEMBL3785103

PubChem CID: 127030046

Max Phase: Preclinical

Molecular Formula: C13H15F2N3O6

Molecular Weight: 347.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1c(F)cccc1F)O/N=C1\N[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

Standard InChI:  InChI=1S/C13H15F2N3O6/c14-5-2-1-3-6(15)8(5)17-13(23)24-18-12-11(22)10(21)9(20)7(4-19)16-12/h1-3,7,9-11,19-22H,4H2,(H,16,18)(H,17,23)/t7-,9-,10+,11-/m1/s1

Standard InChI Key:  DLJKVBGOHTYHDX-CZULRBLNSA-N

Alternative Forms

  1. Parent:

    ALA3785103

    ---

Associated Targets(Human)

GBA1 Tclin Beta-glucocerebrosidase (14647 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

agl1 Alpha-glucosidase (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
lacZ Beta-galactosidase (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Alpha-galactosidase (362 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.27Molecular Weight (Monoisotopic): 347.0929AlogP: -1.13#Rotatable Bonds: 3
Polar Surface Area: 143.64Molecular Species: NEUTRALHBA: 7HBD: 6
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.93CX Basic pKa: 1.78CX LogP: -1.02CX LogD: -1.02
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.30Np Likeness Score: -0.11

References

1. Wang J, Wang X, Zhao Y, Ma X, Wan Y, Chen Z, Chen H, Gan H, Li J, Li L, Wang PG, Zhao W.  (2016)  Synthesis and biological evaluation ofd-gluconhydroximo-1,5-lactam and its oxime-substituted derivatives as pharmacological chaperones for the treatment of Gaucher disease,  (2): [10.1039/C5MD00501A]

Source